Search

everythinglearnresearchcommunity

for

Search:↓

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Almost half of the men with beard hair loss also developed scalp hair loss within a year.

Almost half of the dermatology patients in Eastern Turkey use alternative medicine, which can be risky and delay proper treatment.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Over half of patients had hair loss after weight-loss surgery, especially women, linked to low zinc and vitamin B12 levels.

Over half of the children had abnormal hair under a microscope, with many having genetic hair conditions.

About half of Taiwanese dermatologists use dermoscopy, mainly to improve diagnosis and detect cancer early, but cost and lack of training limit its wider use.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Over half of postmenopausal women experience hair loss, with severity increasing with age, time since menopause, and higher body mass index.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Over half of young people in Saudi Arabia experience early gray hair, linked to factors like smoking, stress, and family history.

Nearly half of the classification tools in the National Institute of Health and Clinical Excellence's Clinical Knowledge Summaries might not effectively guide management for general practitioners.

Over half of the dog skin disorders discussed have known gene variants, enabling genetic testing for diagnosis and responsible breeding.

Over half of the diabetes patients had skin issues, with fungal infections being most common.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

More than half of patients who had acromegaly surgery experienced hair loss, with varying degrees of recovery.

More than half of the women with PCOS in Southern India had Metabolic Syndrome, with large waist circumference being the most common feature.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

More than half of the Thai women with PCOS had polycystic ovarian morphology.

More than half of the young women checked had PCOS, which was linked to inactive lifestyles and poor diets.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Up to half of adult women may experience hair loss, and doctors should use medical history, exams, and tests to find the cause and treat it.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Bimatoprost helped eyelash growth in nearly half of the patients with a type of eyelash hair loss.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.